US 11771776
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted A61KA61K47/6807A61K47/6849
Quick answer
US patent 11771776 (Muscle targeting complexes and uses thereof for treating dystrophinopathies) held by Dyne Therapeutics, Inc. expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Dyne Therapeutics, Inc.
- Grant date
- Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K47/6807, A61K47/6849, A61K47/6889, A61P